BAKHU HOLDINGS, CORP. (BKUH)
| Symbol | BKUH |
|---|
| Name | BAKHU HOLDINGS, CORP. |
|---|
| Sector | UNDEFINED |
|---|
| Region | North America |
|---|
| Industry | - |
|---|
| Address | 90831 United States CA One World Trade Center Suite 130 |
|---|
| Telephone | (858) 682-2548 |
|---|
| Fax | — |
|---|
| Email | — |
|---|
| Website | http://www.bakhuholdings.com |
|---|
| Incorporation | US |
|---|
| Incorporated On | 2008 |
|---|
| Employees | — |
|---|
| Fiscal Year | 7/31 |
|---|
| Public Since | — |
|---|
| Exchanges | OTC |
|---|
| Auditor | — |
|---|
| Audit Status | AUDITED |
|---|
| Reporting Status | U.S. Reporting: SEC Reporting |
|---|
| CIK | 0001440153 |
|---|
| Description | Bakhu Holdings, Corp. holds a license to cell replication technology to produce, manufacture and sell cannabis-related byproducts - sometimes referred in the industry as
cannabinoids - exclusively in North and Central America and the Caribbean. The Company intends to commercialize this technology through sublicenses with third parties who
will use the cell replication technology into production facilities which the sublicensees
fund and build to produce medical, food additive and recreational cannabis-related products.
Additional info from OTC:
Bakhu Holdings, Corp. holds a license to cell replication technology to produce, manufacture and sell cannabis-related byproducts - sometimes referred in the industry as
cannabinoids - exclusively in North and Central America and the Caribbean. The Company intends to commercialize this technology through sublicenses with third parties who
will use the cell replication technology into production facilities which the sublicensees
fund and build to produce medical, food additive and recreational cannabis-related products. |
|---|